ﺑﺎﺯﮔﺸﺖ ﺑﻪ ﺻﻔﺤﻪ ﻗﺒﻠﯽ

خرید پکیج

تعداد آیتم قابل مشاهده باقیمانده : 3 مورد

Recommendations for contraceptive use in SLE patients on chronic medications

Recommendations for contraceptive use in SLE patients on chronic medications

Medication classes and specific medications	Combined hormonal contraceptive	Progesterone-only pill	DMPA
Immunosuppressive
Mycophenolate	Not recommended May decrease efficacy of combined hormonal contraceptive	Unknown	Unknown
Cyclosporine	Use with careful follow-up May increase cyclosporine level	Unknown	Unknown
Glucocorticoid	Use with careful follow-up May increase glucocorticoid level	Unknown	Unknown
Anticoagulant
Warfarin	Avoid or use with careful follow-up Reduces effect of warfarin	Use with careful follow-up Unknown	Use with careful follow-up Unknown
Antiseizure medications
Barbiturates	Not recommended Decreases efficacy of combined hormonal contraceptive	Not recommended	No or minimal risk
Carbamazepine	Not recommended Decreases efficacy of combined hormonal contraceptive	Not recommended	No or minimal risk
Oxcarbazepine	Not recommended Decreases efficacy of combined hormonal contraceptive	Not recommended	No or minimal risk
Topiramate	Not recommended Decreases efficacy of combined hormonal contraception	Not recommended	No or minimal risk
Phenytoin	Not recommended Increases phenytoin concentration and decreases efficacy of combined hormonal contraceptive	Not recommended	No or minimal risk
Lamotrigine	Not recommended Decreases lamotrigine concentration	No or minimal risk	No or minimal risk
Other medications
Modafinil	Not recommended Decreases efficacy of combined hormonal contraceptive	Unknown	Unknown
Potassium-sparing diuretics	Use with careful follow-up Hyperkalemia risk with drospirenone-containing combined hormonal contraceptive	No or minimal risk	No or minimal risk

NOTE: Etonogestrel implant not included due to lack of data.

SLE: systemic lupus erythematosus; DMPA: depomedroxyprogesterone acetate.

Adapted from:

Division of Reproductive Health, National Center for Chronic Disease Prevention and Health Promotion. U.S. Medical Eligibility Criteria for Contraceptive Use, 2010: World Health Organization Medical Eligibility Criteria for Contraceptive Use, 5th edition. MMWR Morb Mortal Wkly Rep 2016; 65:3.
Sammaritano LR. Contraception in patients with rheumatic disease. Rheum Dis Clin North Am 2017; 43:173.

Graphic 98707 Version 5.0

آیا می خواهید مدیلیب را به صفحه اصلی خود اضافه کنید؟